Why the study?
Does low-output cardiac failure increase noradrenaline secretion rates or decrease clearance compared to normal controls?
Does low-output cardiac failure increase noradrenaline secretion rates or decrease clearance compared to normal controls?
Elevated plasma noradrenaline concentrations in patients with mildly decompensated low-output cardiac failure are primarily driven by increased secretion rather than decreased metabolic clearance.
Answers are grounded in this paper and cite their sources.
Supports increased secretion as driver of elevated noradrenaline in low-output HF; leaves open confirmation in larger cohorts and modern therapies.
Plasma noradrenaline concentrations are elevated in patients with congestive heart failure; however, the pathogenesis of these elevated noradrenaline levels is controversial. 2. Possible mechanisms for elevated noradrenaline concentrations in patients with congestive heart failure include increased noradrenaline secretion, decreased clearance of noradrenaline, and a combination of increased secretion and decreased clearance. 3. In the present study, plasma noradrenaline clearance and apparent secretion rates were determined using a whole-body steady-state radionuclide tracer method in six otherwise healthy patients with moderate degrees of low-output cardiac failure and in six normal control subjects. 4. The venous plasma noradrenaline level was elevated in the patients with congestive heart failure as compared with the control subjects (4.18 +/- 1.34 versus 1.54 +/- 0.16 nmol/l, P less than 0.05). There was no stimulation of the adrenal medulla as evident by normal plasma adrenaline levels in both groups (0.19 +/- 0.04 versus 0.18 +/- 0.02 nmol/l, not significant). The apparent secretion rate of noradrenaline was elevated in the patients with congestive heart failure (4.75 +/- 1.95 versus 1.78 +/- 0.18 nmol min-1 m-2, P less than 0.05), whereas the clearance rate of noradrenaline was similar in the two groups (1.26 +/- 0.27 versus 1.16 +/- 0.02 l min-1 m-2, not significant). 5. We conclude that the high peripheral venous plasma noradrenaline concentrations in patients with mildly decompensated low-output cardiac failure are initially due to increased secretion, rather than to decreased metabolic clearance, perhaps in response to diminished effective arterial blood volume.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: